Aptose Biosciences Inc (NAS:APTO)
$ 0.1821 0.0031 (1.73%) Market Cap: 10.62 Mil Enterprise Value: 3.11 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 27/100

Aptose Biosciences Inc Annual Shareholders Meeting Transcript

May 31, 2022 / 05:00PM GMT
Release Date Price: $15.15 (+5.96%)
William G. Rice
Aptose Biosciences Inc. - Chairman, President, CEO & CAO

Good morning, all. I'd like to call to order this Annual Meeting of Shareholders of Aptose Biosciences Incorporated. I'm Dr. William Rice, Chairman of the Board of Directors, President and Chief Executive Officer of Aptose, and I'll be serving as the chair of today's meeting.

Other directors include Dr. Denis Burger, our Lead Independent Director; Mr. Warren Whitehead; Ms. Carol Ashe; Mr. -- Dr. Mark Vincent and Dr. Erich Platzer. Other officers of the company also joining us online today are Dr. Rafael Bejar, Senior Vice President and Chief Medical Officer as well as Dr. Philippe Ledru, our Senior Vice President and Chief Commercial Officer.

It's my pleasure to welcome the shareholders and employees of Aptose and other invited guests to the meeting. As in the past few years, Aptose has opted for a virtual-only Annual Shareholders Meeting. By conducting our meeting online, Aptose aims to provide shareholders with a safe and convenient opportunity to participate without incurring significant travel costs or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot